Ambu A/S Unsponsored ADR (OTCMKTS:AMBBY) Short Interest Update

Ambu A/S Unsponsored ADR (OTCMKTS:AMBBY) saw a significant increase in short interest during the month of August. As of August 31st, there was short interest totaling 26 shares, an increase of 550.0% from the August 15th total of 4 shares. Based on an average daily volume of 743 shares, the short-interest ratio is presently 0.0 days. Approximately 0.0% of the shares of the company are short sold.

Ambu A/S Stock Performance

OTCMKTS:AMBBY opened at $11.00 on Friday. The company’s 50 day moving average is $10.70 and its 200-day moving average is $10.52. The company has a quick ratio of 1.73, a current ratio of 2.92 and a debt-to-equity ratio of 0.08. Ambu A/S has a 12 month low of $8.54 and a 12 month high of $16.78. The firm has a market cap of $2.58 billion, a price-to-earnings ratio of 36.67 and a beta of 0.93.

Ambu A/S (OTCMKTS:AMBBY) last posted its quarterly earnings data on Tuesday, August 25th. The company reported $0.09 earnings per share (EPS) for the quarter. Ambu A/S had a net margin of 8.18% and a return on equity of 8.56%. The business had revenue of $255.12 million during the quarter.

About Ambu A/S

Ambu A/S is a Danish medical technology company that develops, manufactures and markets single-use devices for hospitals and other healthcare providers. The company focuses on reducing the need to reprocess reusable equipment while supporting clinical procedures in areas such as endoscopy, anesthesia and patient monitoring.

Ambu’s product portfolio includes disposable endoscopes and related visualization systems, airway management products, anesthesia equipment and devices used for patient monitoring and diagnostics.